gip glp 1 receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight The Effects of Dual GLP-1/GIP
Description
Reduced risk of side effects
Indias pharma industry is strong
Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease
This infographic breaks down these drugs by active ingredients, brand names and approved uses of popular GLP-1s.
In a trial, people lost 75% fat and 25% muscle.
Obesity and type 2 diabetes remain critical global health challenges, with rising prevalence demanding innovative treatment approaches
